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Abstract
Objective-To establish the reliability and effec-
tiveness of screening for hearing loss by brainstem
auditory evoked potential testing in high risk neo-
nates.
Design-Seven year investigation of newborn
babies admitted to a special care baby unit and
monitored through a regional children's audiology
unit.
Setting-Special care baby unit and children's
audiology department, Belfast.
Subjects-405 neonates admitted to the baby unit,
during 1 October 1982 to 31 March 1987.
Main outcome measures-Presence of hearing
impairment, type and severity ofhearing impairment,
mortality.
Results-85 children failed the screening test, 62
ofwhom were followed up. Five children had severe
bilateral sensorineural impairment and 12 had con-
ductive impairment requiring surgical intervention.
A further 18 had severe neurological disorder
detected. The sensitivity of screening was 100% and
specificity was 88%. If the procedure was introduced
into routine clinical practice the mean age at diag-
nosis for all children with severe perinatal hearing
impairment would be 11 (median 1) months. The
mean age at diagnosis with the health visitor screen-
ing service was 23 (19) months (difference 10 months,
95% confidence interval 6 to 16 months; p<0-0001).
Conclusion-Screening for hearing loss in high
risk neonates is highly reliable and cost effective. It
also provides valuable neurophysiological informa-
tion. Routine testing of these infants would result in
over halfofall children with severe bilateral perinatal
sensorineural hearing impairment being identified by
2 months of age. This would make an important
contribution to the habilitation of this socially,
emotionally, and educationally vulnerable group.
first was to assess the validity and reliability of a
screening programme for high risk neonates. The
second was to compare the relative success of this
programme with existing services and to assess the
potential for improving the service by screening
children at risk. The long term follow up in our study
was made possible by the presence of a single regional
children's audiology unit, to which all children with
suspected hearing impairment were routinely referred
(fig 1). Identification of false negative test results was
also facilitated by the presence of two community
screening tests for all children, one at 7 months and one
at 3 years of age, and by routine pure tone audiometry
at entry to school.
iI Regional audiological service
FIG 1-Flow diagram showing stages leading to full audiological
assessmentfor different methods ofscreening and no screening
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Introduction
Severe prelingual hearing impairment has important
consequences for language acquisition, communica-
tion, and cognitive, social, and emotional develop-
ment.'2 Indeed evidence is increasing that even
moderate hearing loss in very young children can be
detrimental.3 4 It is now generally accepted that appro-
priate remedial measures should be implemented at the
earliest possible age and to this end screening for
hearing loss in preschool children has been imple-
mented in most health districts in the United Kingdom.
The mainstay of current programmes is distraction
testing carried out at 7-9 months of age.5 However,
serious doubts have been raised regarding the efficacy
and cost effectiveness of such programmes, and health
visitor screening has been suggested to be inefficient
and costly and to result in considerable delays in
diagnosis. Attention has increasingly turned towards
developing methods for the early and accurate evalua-
tion of high risk infants.7'0
In view of the uncertainties regarding the relative
merits of these two approaches we began a seven year
study in 1982. The study had two related aims. The
Subjects and methods
The evaluation was based on 405 neonates admitted
to the special care baby unit of the Royal Maternity
Hospital, Belfast, during 1 October 1982 to 31 March
1987. A careful assessment was made of the following
risk factors: familial deafness, rubella infection during
pregnancy, birth weight <1500 g, congenital mal-
formations of the ear, apnoea, asphyxia (Apgar score
<7 at 5 minutes), respiratory difficulty (requiring
respiratory support or more than respiratory oxygen),
sepsis, hyperbilirubinaemia (requiring phototherapy
or exchange transfusion"), and exchange transfusion.
Auditory brainstem evoked potential testing was
usually carried out after any acute conditions had
settled; the modal gestational age was 37 (range 28-42)
weeks. Neonates were investigated in their bassinet or
incubator. Surface electrodes (silver/silver chloride)
were attached to the vertex and both mastoid processes
(impedance <5 kfl). The ear canals were inspected to
ensure they were clear. Sound stimuli were generated
by a Disa audiometer (Disa Elektronik, Denmark)
using 80 ts pulses of alternating polarity delivered
monaurally at a rate of 16 Hz through a TDH 39
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earphone (Instrument Systems, New York) at two
test levels, 30 dB normal hearing level (nHL) and
65 dBnHL.
Electrical activity recorded from vertex and ipsi-
lateral mastoid was amplified x 50000 and analogue,
filtered with a band width of 30-3000 Hz by using
a Grass Model 12 amplifier (Grass Instrument Com-
pany, Quincy, Massachusetts). Averages were formed
from 2048 individual responses with a purpose built
portable microcomputer." The criterion for passing
the test was a definite response at 30 dBnHL in both
ears.
Any child who failed the initial screening test was
referred to the regional audiology unit, where all who
survived were independently assessed and followed
up for a minimum of five years (mean follow up
seven years). Follow up investigation included detailed
otoscopic examination, behavioural audiometry for
younger children and pure tone audiometry for older
children, acoustic impedance testing, and evoked
potential audiometry, as necessary. Based on the
results of follow up children were assigned to one of the
following five categories: normal hearing, conductive
loss, sensorineural loss (including mixed conductive
and sensorineural loss), did not survive, and lost to
follow up.
In addition most children who passed the initial
screening were reviewed at the end of the study
through the clinical medical officer register. This
provided a record of the results of health visitor
screening at 9 months, screening at 3 years, and pure
tone audiometry during the first year of school.
We also analysed data on all children born during the
study period and referred to the regional audiology
unit. These included any child who had passed the
screening test and who was later suspected of having
hearing impairment. In addition to audiological assess-
ment, details of perinatal risk factors were sought.
Analysis of statistical significance was based on
either X2 or Mann-Whitney U tests. The 95% confi-
dence interval was calculated in all cases. The study
was approved by the ethics committee of the faculty of
medicine, Queen's University.
Results
INITIAL SCREENING
A total of 405 neonates were screened. Of these, 85
failed the test and 30 had no responses at 65 dBnHL in
at least one ear (major impairment).
All perinatal risk factors for deafness were positively
associated with a raised auditory threshold, largest
correlations being obtained with Apgar score and
estimated maturity at birth. Fifty two neonates had
Apgar scores of 6 or less at 5 minutes after birth.
Twelve (23%) of the 52 had major impairment
compared with only 16 (5%) of the 342 neonates with
Apgar scores greater than 6 (difference in means 18%,
95% confidence interval 7% to 30%; p<0OOl); Apgar
scores were not available for 11 infants. Eighty five
neonates had gestational ages less than 31 weeks. Of
these, 15 (18%) had major impairment in one or both
ears compared with 15 (5%) of the 320 neonates with
gestational ages of 31 weeks or greater (difference in
means 13%, 9% to 17%; p<000 l).
FOLLOW UP EVALUATION
None of the children who passed the screening test
had been referred to the regional audiology unit with
suspected congenital hearing impairment at the end of
study. Two hundred and thirty three (73%) children
were systematically evaluated through the clinical
medical officer service. All of these were confirmed as
having no perinatal hearing impairment.
Five children who failed the screening test were lost
to follow up due to change of address. Of 19 neonates
who died (15 before discharge from hospital), 18 failed
the screening test. The child who passed the screening
test subsequently died from systemic causes and
without any evidence of neurological or audiological
impairment. The principal aetiological factors in the
other children were severe birth asphyxia with central
nervous system signs (eight children), major congenital
abnormalities (seven), and very low birth weight
(< 1500 g) (three).
Sixty two children who failed the screening test
received follow up audiological evaluation. Hearing
impairment was confirmed in 32 (8% of 405 screened,
5% to 11%). Twenty five children had conductive
impairment, 12 of whom required surgical interven-
tion. Seven children had sensorineural impairment,
including one child with a unilateral non-functioning
ear. Five children required hearing aids (best ear
threshold: mean 76 (range 60-90 dB). One child failed
to attend after the initial follow up.
Twenty seven children passed the initial review and
three children were considered to have normal hearing
at second review. The sensitivity of the test procedure
(number of children with impairment correctly identi-
fied) for the 30 dB stimulus was 100%.
The sensitivity for serious impairment was also
calculated. The test correctly identified 18 children
who had severe neurological and possibly alsQ audio-
logical disorder. Together with the 18 children with
sensorineural or conductive deafness requiring inter-
vention described above, a total of 36 (9% of 405)
children had severe neurological or audiological
impairment (6% to 12%). The corresponding sensitivity
and specificity respectively were 100% and 88% (table).
Response to the high level stimulus (65 dB) alone
gave a sensitivity of 61% and a specificity of 98% for
severe neurological or audiological impairment. Of 14
neonates who had definite responses at screening, four
subsequently died and 10 had severe sensorineural or
conductive losses requiring intervention.
COMPARISON WITH EXISTING SCREENING METHODS
From the register of all children with suspected
hearing impairment in the regional audiology unit we
identified a total of 119 children with severe congenital
bilateral sensorineural impairment born during the
study period. From the registrar general (Northern
Ireland) reports on live births, the estimated incidence
of severe perinatal hearing impairment for the period
was 0 96/1000 live births. Figure 2 compares the
frequency distribution of age at diagnosis in children
in the screening study, in children at risk outside
the study group who were referred to the regional
audiology unit, and in those referred by conventional
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FIG 2-Frequency distributions of age at diagnosis of sensorineural
impairment forfour methods ofdetection: neonatal screening in special
care baby unit, screening by health visitor, referral ofchildren at risk to
regional centre for auditory brainstem evoked potential testing, and
other (children not detected or not screened by health visitor). Mean age
at diagnosis indicated by I
BMJ VOLUME 304 28 MARCH 1992
Sensitivity and specificity of
evoked potential screening for
serious neurological or hearing
impairment
Clinical status
Normal or
Screening Severe minor
result impairment impairment
Fail 36 44
Pass 0 319*
Sensitivity= 100%, specificity=
88%.
*One child who died of systemic
causes was excluded.
m
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routes, usually after health visitor screening. Progres-
sive delays in age at diagnosis were observed. The
largest delays were experienced by those children who
did not receive any screening and whose referral was
initiated by parental suspicion, the mean age at diag-
nosis being 24 (median 1.9) months. However, even
with health visitor screening mean age at diagnosis was
21 (13) months. Children known to be at risk at the
time of birth but who were admitted to special care
units not participating in the study experienced some
delay due to the usual process of referral to the regional
centre for audiological assessment. Their mean age at
diagnosis was 5 (5) months compared with 1 (1) month
in the study group.
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FIG 3-Predicted age at diagnosis in 119 children with sensorineural
impairment if those at risk had been routinely screened at birth and
actual age at diagnosis with current procedures. Mean age at diagnosis
indicated by V
From the histories of the 119 neonates we deter-
mined that definite risk factors were known at birth in
64 (54%) infants. But only 21 neonates, including the
five subjects in our neonatal study, were actually
identified at birth. The remaining 43 were referred by
the more conventional routes. Figure 3 shows what the
substitution of age at diagnosis in the 119 children
would have been if all 64 children at risk had been
given early evoked potential audiometry testing (optimal
screening) and compares this with the actual distri-
bution for those children who did not receive auditory
brainstem evoked potential testing. The mon age at
diagnosis by conventional procedures was 23 (19)
months. The corresponding mean age at diagnosis for a
service which included electrophysiological investi-
gation of all children at risk would be 11 (1) months
(mean difference 10 months 95% confidence interval 6
to 16 months; p<0-0001).
Discussion
The aim of our study was to assess the reliability
and cost effectiveness of auditory brainstem evoked
potential testing in a high risk group of neonates.
The prognostic validity of auditory brainstem evoked
potential testing can be assessed only through careful
and lengthy follow up, but in most studies the follow
up rates are relatively low. In the studies reviewed by
Murray et al follow up data were available on only
13%,'3 and in those reviewed by Jacobson and Hyde
the average retest rate for children who failed the test
was only 60%.'4 In our study outcome information was
obtained on all but five of the children who failed the
initial screening test (94%). In addition, a careful
record has been kept of all children born during the
study period who required audiological assessment.
This provided a unique opportunity to assess the
sensitivity of the method. At the end of 1990, when
the youngest child was 4 years old, none who passed
the initial screening test had been referred with
suspected or confirmed perinatal hearing impairment,
giving a sensitivity of 100%.
COST EFFECTIVENESS
A second issue is cost effectiveness. Several studies
have shown that the positive predictive value of
auditory screening increases if the test procedure is
delayed until infants are 6 months old.95 This has
implications for the efficiency and cost effectiveness of
early screening. We found a positive predictive value of
29-4%-that is, only one child in four who failed the
screening test had confirmed evidence of hearing
impairment requiring intervention. From the narrow
perspective of auditory screening the testing of
children who subsequently died could have been
avoided by delayed testing. On the other hand, the test
correctly identified all children at serious risk of either
neurological or audiological impairment giving a posi-
tive predictive value of 45%. The highest proportions
of children failing the test were observed among very
low birth weight neonates and those whose Apgar score
at 5 minutes was less than 6. Though targeting such
very high risk groups would improve the positive
predictive value, this would be at the cost of failing to
identify several children with hearing impairment.
The issue of cost effectiveness requires considera-
tion of factors other than the test procedure. There are
organisational costs associated with bringing infants
back to the clinic for testing. We had considerable
difficulty in bringing 12 children (15% of those who
failed the test) back for follow up investigation. The
reasons for these difficulties were lack of parental
understanding, transport costs, inability to get baby-
sitters, and ill health among other members of the
family. These difficulties were confined to families
from the lower socioeconomic groups, among whom a
low uptake of health care services is well recognised.
Even greater difficulties and costs probably would have
occurred with many more children had the initial
screening been delayed until 6 months of age.
The cost to the child and the family of delay in
diagnosis must also be considered. The neonatal
nursery provides a unique opportunity to assess all
children at risk. Once newborn babies leave hospital
considerable delays generally occur before hearing
impairment is finally diagnosed.5 10
The efficiency of high risk hearing screening in
neonates can be defined as the number of children
correctly diagnosed as a proportion of the total tested.
In the present study the efficiency for severe sensori-
neural impairment was 1-3%. For all forms of hearing
impairment requiring intervention this rises to 4-5%.
The cost of such a service can also be estimated. From
our experience a skilled technician can investigate and
report on five children a day or 1100 a year (assuming
44 working weeks). With an efficiency of 4-5%,
50 children requiring remedial treatment would be
correctly identified. Our estimated cost of technician
time and equipment is £15 000 a year. This gives an
estimated cost of £300 for each child who has hearing
impairment correctly diagnosed. The efficiency of
auditory brainstem evoked potential screening can be
further improved by using automated methods.'67 In
any cost-benefit analysis the reassurance given to
parents of babies at risk who pass the test must also be
considered.
OTHER SCREENING METHODS
Three objective methods for audiological screening
are currently available: auditory brainstem evoked
potential, the auditory response cradle, and oto-
acoustic emissions. Although we cannot comment on
the relative merits of these three procedures,8 it should
be noted that auditory brainstem evoked potential is
the only test that provides information on the integrity
ofmuch ofthe central auditory pathway. This informa-
tion is of interest for audiological and neurological
evaluation. Many children in special care baby units
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require auditory brainstem evoked potential testing for
neurological investigation in itself. If auditory brain-
stem evoked potential testing is done then two test
intensities should be used, 30 dB for auditory screening
and a high level stimulus to evaluate the morphology
and latencies of the evoked potential components.
CONCLUSIONS
We recommend that all infants in special care baby
units are systematically screened. From our observa-
tions of the regional register, children with a family
history of deafness, congenital and perinatal infection,
or malformations of the head or neck should also be
screened at birth. If all such children were screened
routinely at birth our findings suggest that over half the
children with severe congenital sensorineural impair-
ment could be identified at birth. In addition more
children with conductive impairment who require
treatment would also be detected. Of course a screen-
ing service in isolation is not sufficient. It must be
linked to the full continuum of services embracing
diagnostic evaluation, habilitation, family counselling,
and follow up.
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Comparison of female to male and male to female transmission of
HIV in 563 stable couples
European Study Group on Heterosexual Transmission ofHIV
Abstract
Objective-To identify risk factors for hetero-
sexual transmission of HIV and to compare the
efficiency of male to female and female to male
transmission.
Design-Cohort study of heterosexual couples.
Regular partners of HIV infected subjects were
tested and both members of the couples interviewed
every six months. HIV prevalence in partners was
analysed according to the characteristics of the
couples.
Setting-Nine European countries.
Subjects-563 couples comprising 156 female
index patients with their 159 male partners and 400
male index patients with their 404 female partners.
Partners reporting risk factors other than sexual
contacts with the index patient were excluded.
Main outcome measures-HIV infection in
partners and high risk sexual behaviour.
Results-Overall, 19 (12%) male partners and 82
(20%) female partners were infected with HIV,
suggesting that male to female transmission is 1*9
(95% confidence interval 1.1 to 3.3) times more
effective than female to male transmission. An
advanced stage of HIV infection in the index patient
(odds ratio 17-6; 4-9 to 62.7) and sexual contacts
during menses (3.4; 1-0 to 11-1) increased the risk of
female to male transmission and stage of infection
(2.7; 1-5 to 4.9), anal sex (5-1; 2-9 to 8.9), and age of
the female partner (3.9; 1-2 to 13-0 for age >45 years)
increased the risk of male to female transmission.
None of the 24 partners who had used condoms
systematically since the first sexual contact was
infected.
Conclusions-Several factors which potentiate
the risk of transmission through unprotected vagi-
nal intercourse have been identified. Knowledge
of these factors could be helpful for counsel-
ling patients infected with HIV and their sexual
partners.
Introduction
Several studies have examined the risk of sexual
transmission ofHIV from infected men to their female
partners.'7 HIV prevalence among female partners of
infected men ranges from 15% to 30% in most studies
from Europe and the United States. In addition to
unprotected vaginal intercourse anal sex and advanced
clinical or immunological stage of HIV infection in
men have been shown to significantly increase the risk
of transmission.
Since many more men are infected with HIV than
women in most developed countries, transmission
from infected women to their male partners has been
poorly studied. Even in regions where HIV is predomi-
nantly acquired through heterosexual contact few data
are available. Only one large study on clients of
prostitutes has been published.8
We present the results of a European multicentre
study, the aims of which are to measure the risk of and
identify the risk factors for heterosexual transmission;
to compare the relative efficiency ofmale to female and
female to male transmission; and to assess the effective-
ness of counselling safer sex through the prospective
follow up of couples. The preliminary results on male
to female transmission of HIV have been published.'
This paper focuses on the analysis of the risk of female
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